RecruitingNCT07205341

Detecting Changes in Arterial Blood Volume and Cardiac Efficiency

HemoCept Inc.One US siteView on ClinicalTrials.gov

AI Description

The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.

Report inaccurate information

Who can join
adult, older adult
Participants
20
Expected completion
2026-09
Funded by
industry

Conditions studied

Aortic Valve Stenosis

What it measures

  • Correlation of HemoCept device measurements with aortic valve pressure gradient changes., The primary endpoint is the ability of the HemoCept device to properly detect changes consistent with aortic valve pressure gradient values, measured by echocardiogram pre and post TAVR procedure., Perioperative; immediately before procedure, and up to 24 hours after the procedure

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-04-13

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.